NewEdge Advisors’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$519K Sell
15,956
-791
-5% -$25.4K ﹤0.01% 1963
2025
Q4
$589K Buy
16,747
+139
+0.8% +$4.92K ﹤0.01% 1853
2025
Q3
$436K Sell
16,608
-1,147
-6% -$34.2K ﹤0.01% 1914
2025
Q2
$471K Buy
17,755
+15,418
+660% +$406K ﹤0.01% 1732
2025
Q1
$56.4K Buy
2,337
+269
+13% +$8.5K ﹤0.01% 2515
2024
Q4
$83.2K Buy
2,068
+1,076
+108% +$61.4K ﹤0.01% 2343
2024
Q3
$62.8K Sell
992
-10,532
-91% -$618K ﹤0.01% 2360
2024
Q2
$611K Sell
11,524
-2,093
-15% -$137K ﹤0.01% 1301
2024
Q1
$1.12M Buy
13,617
+13,023
+2,192% +$579K 0.01% 951
2023
Q4
$11.1K Buy
+594
New +$7.77K ﹤0.01% 2800

Other funds holding VKTX